The Anesthetic Management for a Patient With Trisomy 13

Masanori Tsukamoto1, Takashi Hitosugi1, Kanako Esaki1

  • 1Department of Dental Anesthesiology, Kyushu University Hospital, Fukuoka, Japan.

Anesthesia Progress
|September 1, 2017
PubMed

Insights

Trisomy 13 patients, often with severe health issues, can undergo dental treatment safely. Monitoring cardiac and seizure activity ensures successful oral care for improved quality of life.

Area of Science:

  • Genetics and chromosomal abnormalities
  • Pediatric medicine
  • Dental medicine

Background:

  • Trisomy 13 (Patau syndrome) is a severe chromosomal disorder with a poor prognosis, often leading to early mortality.
  • Patients with Trisomy 13 frequently exhibit developmental delays, seizures, and congenital heart defects, impacting overall health and quality of life.

Observation:

  • Special needs patients, including those with Trisomy 13 and mental retardation, often present with compromised oral health.
  • This case involved a young patient with Trisomy 13, a history of ventricular septal defect closure, mental retardation, and seizures.

Findings:

  • Dental treatment was successfully completed in a Trisomy 13 patient with significant comorbidities.
  • Non-invasive monitoring, including cardiac electric velocimetry and epileptogenic activity assessment, ensured patient safety during dental procedures.
  • Postoperative respiratory function remained stable, allowing the patient to breathe room air.

Implications:

  • This case demonstrates the feasibility and safety of providing essential dental care to patients with Trisomy 13 under appropriate monitoring.
  • Optimizing oral health can contribute to the overall well-being and daily functioning of individuals with severe chromosomal disorders.
  • Highlights the importance of multidisciplinary care, integrating dental, cardiac, and neurological monitoring for high-risk pediatric patients.

Related Concept Videos

Parenteral Anesthetics: Overview01:24

Parenteral Anesthetics: Overview

Intravenous anesthetics are drugs administered parenterally to induce anesthesia or sedation. Propofol is a widely used agent formulated as a 1% emulsion in soybean oil, glycerol, and egg phosphatide. It induces rapid anesthesia primarily due to its rapid distribution from the bloodstream to target tissues and is metabolized in the liver. However, it can cause significant pain on injection and hypertriglyceridemia. Fospropofol, a water-based prodrug of propofol, lacks these adverse effects.
805
General Anesthesia: Overview01:24

General Anesthesia: Overview

Anesthesia is a medical procedure that uses drugs for CNS suppression to enable painless surgeries and procedures. The selection of anesthetics is influenced by their pharmacokinetic properties, side effects, and patient characteristics. Various types of anesthesia include general, local, regional, spinal, and inhalational.
General anesthesia induces unconsciousness in the whole body, while the others target specific areas or sensations. It is administered to minimize adverse effects, maintain...
862
Depolarizing Blockers: Pharmocokinetics01:19

Depolarizing Blockers: Pharmocokinetics

Depolarizing blockers are administered through intravenous injection. Succinylcholine is the most common choice of depolarizing blockers in emergency clinical practices. Although they have a rapid onset, they readily diffuse away from the motor end plate into the extracellular fluid. They are metabolized by enzymes such as liver butyrylcholinesterase and plasma pseudocholinesterases. This produces a short duration of action, typically 5-10 minutes long, unlike nondepolarizing blockers, which...
646
Skeletal Muscle Relaxants: Therapeutic Uses01:31

Skeletal Muscle Relaxants: Therapeutic Uses

Skeletal muscle relaxants are used to relax muscle tone and alleviate painful muscle contractions. However, the choice of skeletal muscle relaxants depends on the duration of the surgical procedure in order to minimize potential side effects. Skeletal muscle relaxants like neuromuscular blocking agents [NMBAs] are commonly employed as adjuvants alongside general anesthetics in clinical settings. NMBAs are also used to maintain controlled ventilation during surgery of the larynx or pharynx...
1.1K
Inhalational Anesthetics: Overview01:20

Inhalational Anesthetics: Overview

Inhalation anesthetics are drugs that induce general anesthesia upon inhalation. They work by increasing the sensitivity of GABAA receptors or inhibiting NMDA receptors, leading to a decrease in central nervous system activity. The depth of anesthesia can be rapidly adjusted by changing the concentration of the inhaled gas. Some common examples of inhalational anesthetics include volatile liquids like isoflurane, desflurane, sevoflurane and gases like xenon and nitrous oxide. Isoflurane, a...
1.3K
Stages of General Anesthesia01:22

Stages of General Anesthesia

Various sedation levels offer significant advantages in facilitating procedural interventions for patients undergoing medical or invasive surgical procedures. These levels span from anxiolysis to general anesthesia, providing a spectrum of sedative effects to cater to specific patient needs. Anxiolysis reduces anxiety and is achieved through minimal sedation, enabling patients to remain awake and responsive while feeling more at ease during the procedure. This level can benefit minor...
1.9K